Top Investments For 2015

Quantum International Corp. (QUAN)

Today, QUAN surged (+2.86%) up +0.005 at $.180 with 160,170 shares in play thus far (ref. google finance Delayed: 11:43AM EDT June 24, 2013).

As Apple is expected to release the iPad 5 this summer, Quantum International Corp. is readying to enter the exploding $2.3 billion iPad accessories market as work continues on the company��s first prototype case.

With iPads becoming more and more prevalent in the professional environment as well as for education and entertainment, Quantum��s engineering partners are hard at work developing an amazing and innovative case that will provide users with many exciting options. The case will be the debut offering in Quantum��s lifestyle enhancement product line.

Take a look at Quantum International Corp. (QUAN) 5 day chart:

Top Construction Companies To Buy Right Now: Vail Resorts Inc. (MTN)

Vail Resorts, Inc., through its subsidiaries, operates resorts in the United States. The company operates in three segments: Mountain, Lodging, and Real Estate. The Mountain segment operates eight ski resort properties, including the Vail Mountain, Breckenridge Ski, Keystone, Beaver Creek, Heavenly Mountain, Northstar, Kirkwood Mountain, and Canyons resorts; and two urban ski areas, such as Afton Alps and Mount Brighton Ski areas, as well as provides ancillary services, primarily ski school, dining, and retail/rental operations. Its resorts offer various recreational activities comprising skiing, snowboarding, snowshoeing, snowtubing, sightseeing, mountain biking, guided hiking, children's activities, and other recreational activities, as well as ski and snowboard lessons, equipment rental and retail merchandise services, dining venues, and private club services. This segment also leases its owned and leased commercial space; and provides real estate brokerage services. Th e Lodging segment owns and/or manages a collection of luxury hotels under the RockResorts brand, and other lodging properties; various condominiums located in and around the company�s ski resorts; destination resorts; and golf courses, as well as offers resort ground transportation services. This segment operates approximately 5,100 owned and managed hotel and condominium rooms. The Real Estate segment owns, develops, markets, and sells real estate properties in and around the company�s resort communities. Vail Resorts, Inc. was founded in 1997 and is based in Broomfield, Colorado.

Advisors' Opinion:

• [By Seth Jayson]

  Vail Resorts (NYSE: MTN  ) reported earnings on June 6. Here are the numbers you need to know.

  The 10-second takeaway
  For the quarter ended April 30 (Q3), Vail Resorts met expectations on revenues and missed estimates on earnings per share.

• [By Dan Caplinger]

  Winter has been kind to Arctic Cat and a number of other companies that rely on snow for their business. Ski-resort operator Vail Resorts (NYSE: MTN  ) got out to a slow start this season, leading to an earnings shortfall for its January quarter, but better snow totals later in the season have sent its stock rising sharply. Arctic Cat hopes to benefit from the same conditions.

• [By Rick Aristotle Munarriz]

  Craig Warga/Bloomberg via Getty Images You can never know in advance all the news that will move the market in a given week, but some things you can see coming. From earnings reports to a new "Hobbit" film, let's take a look at the business news that will break in the week ahead. Monday -- Let it Snow, Let it Snow, Let it Snow: Ski resorts are open for the season, and we'll get a great early read on how the business is holding up when Vail Resorts (MTN) reports fresh financials after Monday's market close. True to its name, Vail Resorts operates a ski property in Vail as well as nearby slopes in Beaver Creek, Breckenridge and Keystone in Colorado. It also owns resorts in six different snowy states. Don't expect a quarterly profit out of Vail Resorts. The months of August, September, and October are naturally forgettable for ski resorts. Vail expects to generate four times as much revenue during the next three months as it did during the period that ended in October. However, Vail Resorts should be able to offer a glimpse about how the new ski season is starting to shape up. It has enough advance booking information to know what folks are willing to pay this year for a trek out to the slopes. Tuesday -- For Whom the Bell Tolls: It's once again great time to be a real estate developer. Home prices are moving higher, and those increases are moving at a headier clip than the costs to build new digs. We'll get a good snapshot of the housing industry when Toll Brothers (TOL) reports on Tuesday. The builder of upscale properties is typically blunt about its assessment, and naturally the news has been good in recent quarters as home buyers aren't walking away from their contracts, and asking prices keep inching up. Hovnanian (HOV) -- another developer that offers more accessibly priced properties -- reports two days later. Analysts see revenue surging 56 percent at Toll and 19 percent at Hovnanian. It's good to be a builder right now, but that won't remain that way i

Top Investments For 2015: Prothena Corporation PLC (PRTA)

Prothena Corporation PLC, incorporated on September 26, 2012, is an Ireland-based, clinical-stage biotechnology company. The Company is engaged in discovering and developing monoclonal antibodies that are directed towards misfolded proteins or improper cell adhesion. Its pipeline includes NEOD001, PRX002 and PRX003. The Company��s work in protein misfolding could result in therapies to treat several neurodegenerative diseases, including AL (primary) and AA (secondary) forms of amyloidosis (NEOD001), Parkinson's disease and related synucleinopathies (PRX002). Its cell adhesion development activities could generate new therapies to treat inflammatory diseases and metastatic cancers (PRX003). The Company��s program, NEOD001, is in Phase 1. In addition to antibodies directed to neo-epitope targets, it is developing antibodies directed to other targets. The Company has generated antibodies against cell adhesion targets expressed on certain pathogenic Th17 immune cells and tumor cells.

The Company��s pipeline also includes several late discovery stage programs for which it is testing antibodies in preclinical models of disease. It is also generating additional antibodies against other targets involved in protein misfolding and cell adhesion for characterization in vivo and in vitro.

NEOD001 for Amyloidosis

NEOD001 is a monoclonal antibody that targets the amyloid that accumulates in both AL and AA forms of amyloidosis. The antibody was designed to not react with normal serum amyloid A and only with the aberrant cleaved form of the protein (amyloid A).

PRX002 for Parkinson��s Disease

The Company has generated antibodies targeting alpha-synuclein that may slow or reduce the neurodegeneration associated with synuclein misfolding and/or transmission. It has tested these antibodies in various cellular and animal models of synuclein-related disease. In a transgenic mouse model of Parkinson��s disease, passive immunization with 9E4, a murine ver! sion of PRX002, reduced the appearance of synuclein pathology, protected synapses and improved performance by the mice in behavioral testing. The humanized antibody product candidate PRX002 has advanced into manufacturing and preclinical testing.

PRX003 for Inflammatory Diseases and Cancers

The Company is developing PRX003, a monoclonal antibody targeting MCAM for the potential treatment of inflammatory diseases and cancers. It has generated monoclonal antibodies that block MCAM-mediated cell adhesion and have been shown to delay relapse and severity of relapse in a mouse model of multiple sclerosis known as experimental autoimmune encephalomyelitis. The Company��s antibodies are being tested in animal models of inflammatory diseases and cancers. Based on early results from these studies, it has identified a clinical candidate, PRX003. It has advanced this antibody into manufacturing and intends to advance this antibody into preclinical testing.

Advisors' Opinion:

• [By Lisa Levin]

  Prothena Corporation plc (NASDAQ: PRTA) shares surged 23.52% to touch a new 52-week high of $45.90 after the company reported clinical data to be presented at International Symposium on Amyloidosis. Morgan Stanley raised the price target on the stock from $35.00 to $53.00.

• [By MONEYMORNING]

  For its part, CSD also is tapping into the biotech boom. The second firm that it holds and we like is Prothena Corporation PLC (Nasdaq: PRTA), a clinical-stage biotechnology firm focused on Parkinson's disease and other neurodegenerative disorders.

• [By Jake L'Ecuyer]

  Shares of Prothena Corporation plc (NASDAQ: PRTA) got a boost, shooting up 6.99 percent to $32.00 after the company reported the successful start of a Phase 1 clinical trial of PRX002 for the treatment of Parkinson's disease. Citigroup initiated coverage on the stock with a Buy rating and a $50.00 price target.

Top Investments For 2015: Precision Drilling Corp (PDS)

Precision Drilling Corporation (Precision) is a provider of contract drilling and completion and production services primarily to oil and natural gas exploration and production companies in Canada and the United States. The Company operates in two segments: Contract Drilling Services, and Completion and Production Services. In Canada, the Contract Drilling Services segment includes land drilling services, directional drilling services, procurement and distribution of oilfield supplies and the manufacture and refurbishment of drilling and service rig equipment, and the Completion and Production Services segment includes service rigs for well completion and workover services, snubbing services, camp and catering services, wastewater treatment services and the rental of oilfield surface equipment, tubulars, well control equipment and wellsite accommodations. Advisors' Opinion:

• [By Lee Jackson]

  Precision Drilling Corp. (NYSE: PDS) is Canada’s leading oilfield services firm, which provides contract drilling, well servicing and strategic support services to its customers. The company was formed as a private drilling contractor in the early 1950s and has grown on the back of fleet expansion and acquisitions, most notably the $2 billion purchase of Grey Wolf in 2008. The company pays investors a 2.1% dividend. The Jefferies price objective goes from $11 to $13. The consensus stands at $12.78. The stock closed Friday at $10.39.

Top Investments For 2015: Spdr Dj Wilshire Small Cap Etf (SLY)

SPDR DJ Wilshire Small Cap ETF (the Fund), formerly streetTRACKS DJ Wilshire Small Cap ETF, seeks to replicate as closely as possible the total return of the Dow Jones Wilshire Small Cap Index (the Index). The Index is a float-adjusted market capitalization weighted index that reflects the shares of securities of the small-cap portion of the Dow Jones Wilshire 5000 Composite Index actually available to investors in the marketplace. The Index includes the components ranked 751 to 2,500 by full market capitalization. The Index consists of common stocks selected for their capitalization. The composition of the Index is reviewed semiannually in March and December. Shares and float factors of the Index are updated on a quarterly basis.

The Fund utilizes a passive or indexing approach and attempts to approximate the investment performance of its Index, by investing in a portfolio of stocks intended to replicate the Index. The Fund��s investment manager is SSgA Funds Management, Inc.

Advisors' Opinion:

• [By Will Ashworth]

  By the time the dust settled in 2013, small caps won the day (well, year) — the SPDR S&P SmallCap 600 (SLY) had outperformed the SPDR S&P 500 ETF (SPY) by almost 9 percentage points.

• [By Dan Caplinger]

  Where the best gains are
  In fact, when you compare returns across stocks of various sizes, you'll get some surprising results:

  The SPDR S&P 500 ETF (NYSEMKT: SPY  ) weighs in with 20% gains with its exposure to 500 of the largest companies in the U.S. market. When you step down to mid-cap stocks, though, you'll get even better returns, with the SPDR S&P MidCap 400 ETF (NYSEMKT: MDY  ) posting returns of 21% so far in 2013, based on the performance of 400 mid-sized companies domestically. The smallest companies in the market have done better still, as the SPDR S&P SmallCap 600 ETF (NYSEMKT: SLY  ) has given investors impressive 24% returns since Jan. 1.

  Why are smaller companies outperforming the largest stocks in the market? Historically, smaller stocks have posted better long-term returns than their larger counterparts, with theoreticians pointing to the greater risk involved in small-cap stocks as justifying the higher risk premium that investors should demand in order to hold them over the long run.